Stroke at baseline of the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil)
a cross-sectional analysis
Keywords:
Cerebrovascular disorders, Stroke, Risk factor, Secondary preventionAbstract
BACKGROUND: Secondary prevention of stroke is a very important goal for achieving continuous reduc- tion in stroke mortality rates over the next decades. DESIGN AND SETTING: Cross-sectional analysis on the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil), with data from Salvador, Vitória, Belo Horizonte, Rio de Janeiro, São Paulo and Porto Alegre. METHODS: This descriptive analysis focused on secondary prevention of stroke among participants who self-reported a medical diagnosis of stroke at the baseline of ELSA-Brasil, and its association with sociode- mographic characteristics. RESULTS: Overall, 197 participants (1.3%) reported a prior medical history of stroke. Participants with stroke were older and less educated and had lower mean monthly family income, compared with non- stroke participants. Among all stroke cases, 23.7% did not use any medication for secondary prevention of stroke. Use of secondary prevention was higher among men than among women (respectively, 59.6% versus 40.4%; P = 0.02 for aspirin; and 71.4% versus 28.6%; P = 0.04 for other antiplatelet drugs). Hav- ing private health insurance was associated with greater use of less cost-effective and more expensive medications (like angiotensinogen receptor blockers) and a tendency to use antiplatelet drugs other than aspirin, among participants reporting stroke, compared with others. Use of medication decreased as time passed after suffering a stroke. CONCLUSIONS: In this sample of individuals with better access to healthcare services, use of secondary prevention for stroke was low, which may suggest that the situation in the general population is worse. Sex was the most important sociodemographic variable associated with low use of secondary prevention.
Downloads
References
GBD 2015 Mortality and Causes of Death Collaborators. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016;388(10053):1459-544. PMID: 27733281; doi: 10.1016/S0140-6736(16)31012-1.
Feigin VL, Mensah GA, Norrving B, et al. Atlas of the Global Burden of Stroke (1990-2013): The GBD 2013 Study. Neuroepidemiology. 2015;45(3):230-6. PMID: 26505985; doi: 10.1159/000441106.
Lotufo PA, Goulart AC, Passos VMA, et al. Cerebrovascular disease in Brazil from 1990 to 2015: Global Burden of Disease 2015. Rev Bras Epidemiol. 2017;20Suppl 01(Suppl 01):129-41. PMID: 28658378; doi: 10.1590/1980-5497201700050011.
Lotufo PA, Goulart AC, Fernandes TG, Benseñor IM. A reappraisal of stroke mortality trends in Brazil (1979-2009). Int J Stroke. 2013;8(3):155-63. PMID: 22297034; doi: 10.1111/j.1747-4949.2011.00757.x.
Fernandes TG, Bando DH, Alencar AP, Benseñor IM, Lotufo PA. Income inequalities and stroke mortality trends in Sao Paulo, Brazil, 1996-2011. São Paulo Med J. 2015;133(6):4579. PMID: 26044779; doi: 10.1111/ijs.12526.
Cabral NL, Franco S, Longo A, et al. The Brazilian Family Health Program and secondary stroke and myocardial infarction prevention: a 6-year cohort study. Am J Public Health. 2012;102(12):e90-5. PMID: 23078478; doi: 10.2105/AJPH.2012.301024.
Vianna CA, González DA, Matijasevich A. Utilização de ácido acetilsalicílico (AAS) na prevenção de doenças cardiovasculares: um estudo de base populacional [Aspirin use in cardiovascular disease prevention: a population-based study]. Cad Saúde Pública. 2012;28(6):1122-32. PMID: 22666816; doi: 10.1590/S0102-311X2012000600011.
Aquino EM, Barreto SM, Benseñor IM, et al. Brazilian Longitudinal Study of Adult Health (ELSA-Brasil): objectives and design. Am J Epidemiol. 2012;175(4):315-24. PMID: 22234482; doi: 10.1093/aje/kwr294.
Schmidt MI, Duncan BB, Mill JG, et al. Cohort Profile: Longitudinal Study of Adult Health (ELSA-Brasil). Int J Epidemiol. 2015;44(1):68-75. PMID: 24585730; doi: 10.1093/ije/dyu027.
Benseñor IM, Griep RH, Pinto KA, et al. Rotinas de organização de exames e entrevistas no centro de investigação ELSA-Brasil [Routines of organization of clinical tests and interviews in the ELSA-Brasil investigation center]. Rev Saúde Pública. 2013;47 (suppl 2):37-47. PMID: 24346719; doi: 10.1590/S0034-8910.2013047003780.
Mill JG, Pinto K, Griep RH, et al. Aferições e exames clínicos realizados nos participantes do ELSA-Brasil [Medical assessments and measurements in ELSA-Brasil]. Rev Saúde Pública. 2013;47(Suppl 2):54-62. PMID: 24346721; doi: 10.1590/S0034-8910.2013047003851.
Santos IS, Bittencourt MS, Oliveira IR, et al. Carotid intima-media thickness value distributions in the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil). Atherosclerosis. 2014;237(1):227-35. PMID: 25244507; doi: 10.1016/j.atherosclerosis.2014.09.004.
Stoverinck MJ, Lagro-Janssen AL, Weel CV. Sex differences in health problems, diagnostic testing, and referral in primary care. J Fam Pract. 1996;43(6):567-76. PMID: 8969705.
Koutis AD, Isacsson A, Lindholm LH, et al. Use of primary health care in Spili, Crete, and in Dalby, Sweden. Scand J Prim Health Care. 1991;9(4):297-302. PMID: 1792458.
Aquino EM, Menezes GM, Amoedo MB. Gênero e saúde no Brasil: considerações a partir da Pesquisa Nacional por Amostra de Domicílios [Gender and health in Brazil: considerations based on the National Household Sampling Survey]. Rev Saúde Pública. 1992;26(3):195-202. PMID: 1342501; doi: 10.1590/S0034-89101992000300011.
Bermudez JA, Barros MB. Perfil do acesso e da utilização de medicamentos da população brasileira – contribuições e desafios da PNAUM – Inquérito Domiciliar [Profile of access and use of medicines in the Brazilian population – contributions and challenges of PNAUM – Household Survey]. Rev Saúde Pública. 2016;50(suppl 2):2s. PMID: 27982385; doi: 10.1590/s1518-8787.201605000supl2ap.
Brasil. Portaria no 3.916. Diário Oficial da União 1998 novembro 10:18 (s. 1, n. 215-E). Available from: http://bvsms.saude.gov.br/bvs/saudelegis/gm/1998/prt3916_30_10_1998.html. Accessed in 2018 (Jun 11).
Brasil. Ministério da Saúde. Secretaria de Ciência, Tecnologia e Insumos Estratégicos. Departamento de Assistência Farmacêutica e Insumos Estratégicos. Relação Nacional de Medicamentos Essenciais: RENAME 2014 / Ministério da Saúde, Secretaria de Ciência, Tecnologia e Insumos Estratégicos, Departamento de Assistência Farmacêutica e Insumos Estratégicos. – 9. ed. rev. e atual. – Brasília: Ministério da Saúde, 2015.
Brasil. Ministério da Saúde, Fundação Oswaldo Cruz. Programa Farmácia Popular do Brasil: manual básico/Ministério da Saúde, Fundação Oswaldo Cruz. Brasília: Editora do Ministério da Saúde; 2005. Available from: http://bvsms.saude.gov.br/bvs/publicacoes/PROGRAMA_FARMACIA_POPULAR.pdf. Accessed in 2018 (Jun 11).
Yamauti SM, Barberato-Filho S, Lopes LC. Elenco de medicamentos do Programa Farmácia Popular do Brasil e a Política de Nacional Assistência Farmacêutica [The list of drugs in the Popular Pharmacy Program and the Brazilian National Pharmaceutical Care Policy]. Cad Saúde Pública. 2015;31(8):1648-62. PMID: 26375644; doi: 10.1590/0102-311X00054814.
Pinto C du B, Miranda ES, Emmerick IC, Costa N do R, Castro CG. Preços e disponibilidade de medicamentos no Programa Farmácia Popular do Brasil [Medicine prices and availability in the Brazilian Popular Pharmacy Program]. Rev Saúde Pública. 2010;44(4):611-9. PMID: 20585741; doi: 10.1590/S0034-89102010005000021.
Guerra AA Jr, Acúrcio F de A, Gomes CA, et al. Disponibilidad de medicamentos esenciales en dos regiones de Minas Gerais, Brasil [Availability of essential drugs in two regions of Minas Gerais, Brazil]. Rev Panam Salud Publica. 2004;15(3):168-75. PMID: 15096289.
Dal Pizzol T da S, Trevisol DJ, Heineck I, et al. Adesão a listas de medicamentos essenciais em municípios de três estados brasileiros [Adherence to essential medicines in cities from three Brazilian states]. Cad Saúde Pública. 2010;26(4):827-36. PMID: 20512222; doi: 10.1590/S0102-311X2010000400024.
Gamboa CM, Colantonio LD, Brown TM, Carson AP, Safford MM. Race-Sex Differences in Statin Use and Low-Density Lipoprotein Cholesterol Control Among People with Diabetes Mellitus in the Reasons for Geographic and Racial Differences in Stroke Study. J Am Heart Assoc. 2017;6(5). pii: e004264. PMID: 28490523; doi: 10.1161/JAHA.116.004264.
Mosca L, Linfante AH, Benjamin EJ, et al. National study of physician awareness and adherence to cardiovascular disease prevention guidelines. Circulation. 2005;111(4):499–510. PMID: 15687140; doi: 10.1161/01.CIR.0000154568.43333.82.
Kernan WN, Ovbiagele B, Black HR, et al. Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2014;45(7):2160-236. PMID: 24788967; doi: 10.1161/STR.0000000000000024.
Chor D, Pinho Ribeiro AL, Sá Carvalho M, et al. Prevalence, Awareness, Treatment and Influence of Socioeconomic Variables on Control of High Blood Pressure: Results of the ELSA-Brasil Study. PLoS One. 2015;10(6):e0127382. PMID: 26102079; doi: 10.1371/journal. pone.0127382.
Picon RV, Fuchs FD, Moreira LB, Riegel G, Fuchs SC. Trends in prevalence of hypertension in Brazil: a systematic review with meta-analysis. PLoS ONE. 2012;7(10):e48255. PMID: 23118964; doi: 10.1371/journal. pone.0048255.
Carrington MJ, Jennings GL, Stewart S. Pressure points in primary care: blood pressure and management of hypertension in 532050 patients from 2005 to 2010. J Hypertens. 2013;31(6):1265-71. PMID: 23552128; doi: 10.1097/HJH.0b013e3283606bc7.
Fasce E, Campos I, Ibáñez P, et al. Trends in prevalence, awareness, treatment and control of hypertension in urban communities in Chile. J Hypertens. 2007;25(9):1807-11. PMID: 17762644; doi: 10.1097/HJH.0b013e328244e481.
Guo F, He D, Zhang W, Walton RG. Trends in prevalence, awareness, management, and control of hypertension among United States adults, 1999 to 2010. J Am Coll Cardiol. 2012;60(7):599-606. PMID: 22796254; doi: 10.1016/j.jacc.2012.04.026.
Lotufo PA, Benseñor IM. Stroke mortality in Brazil: one example of delayed epidemiological cardiovascular transition. Int J Stroke. 2009;4(1):40-1. PMID: 19236497; doi: 10.1111/j.1747-4949.2009.00240.x.
Lotufo PA. Stroke is still a neglected disease in Brazil. Sao Paulo Med J. 2015;133(6):457-9. PMID: 26760122; doi: 10.1590/1516-3180.2015.13360510.